Aldeyra Therapeutics, Inc.
ALDX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $296,830 | $206,890 | $406,506 | $216,168 |
| - Cash | $54,527 | $142,823 | $144,419 | $229,791 |
| + Debt | $15,303 | $15,657 | $16,084 | $15,859 |
| Enterprise Value | $257,606 | $79,724 | $278,171 | $2,236 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$53,676 | -$35,208 | -$60,072 | -$55,770 |
| % Margin | – | – | – | – |
| Net Income | -$55,851 | -$37,543 | -$62,025 | -$57,776 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.94 | -0.64 | -1.06 | -1.07 |
| % Growth | -46.9% | 39.6% | 0.9% | – |
| Operating Cash Flow | -$43,209 | -$30,326 | -$56,637 | -$42,556 |
| Capital Expenditures | $0 | $0 | -$16 | -$8 |
| Free Cash Flow | -$43,209 | -$30,326 | -$56,654 | -$42,564 |